Clinical trials
Hyperlipidemias trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 9 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 5 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 6 |
| Pfizer | 5 |
| Takeda | 5 |
| Imperial College London | 3 |
| Novartis Pharmaceuticals | 3 |
| Esperion Therapeutics, Inc. | 2 |
| Kastle Therapeutics, LLC | 2 |
| King's College London | 2 |
| University of Bath | 2 |
| 89bio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 40 |
| Hypercholesterolemia | 16 |
| Dyslipidemias | 10 |
| Cardiovascular Diseases | 6 |
| Hyperlipoproteinemia Type II | 5 |
| Metabolic Diseases | 4 |
| Homozygous Familial Hypercholesterolemia | 3 |
| Hyperlipoproteinemias | 3 |
| Lipid Metabolism Disorders | 3 |
| Myocardial Infarction | 3 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.